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Supplementary Figure S1. Virus-like particles (VLP) identification and shotgun metagenomics. (a) VLP was 
detected in urine of the transplant patients by SyBr Gold staining. The VLP appear as dim pinpoints (denoted by 
blue arrows) and the microbial cells which are larger and brighter (denoted by red arrows). (b) The sequences were 
filtered to remove human reads. The total number of virus sequences identified in each group, are significantly 
different. The difference was computed using Welch t-test, ***p<0.001. (c) Total number of sequences (non-human 
and non-virus) identified after filtering for virus reads in BKV+ and BKV- samples. No significant (ns) difference 
was observed in each group. (d) Bar graph representation for distribution of total number of virus, bacteria, 
eukaryotic and unclassified reads among BKV+ and BKV- samples. (e) BKV, (f) JCV and (g) TTV counts in BKV+ 
and BKV- groups. BKV was dominant in the BKV+ group and was statistically significant among the groups. The 
difference was computed using Welch t-test, ***p<0.001. There was no significant (ns) difference among the JCV 










Supplementary Figure S2. BKV+ and BKV- group patient’s demographics. No correlation was 
observed between patient’s demographics and clinical diagnosis with the status of viremia or viruria in 























Supplementary Figure S3. Species specific phylogenetic analysis for BK virus. Phylogenetic tree 
analysis is based on the whole genome sequences of the 26 species-specific distinct BKV strains and 
sequences from this study [e.g. the B19/A-62H (1a) sequence]. Our sequence clustered adjacent to the 
human BKV Dunlop (1a) reference strain described in this study. The evolutionary history was inferred by 
using the Maximum Likelihood method based on the Tamura-Nei model. The bootstrap consensus tree 
inferred from 100 replicates is taken to represent the evolutionary history of the taxa analyzed. The tree is 


































Supplementary Figure S4.  (a) Reference genome mapping for BK virus (a), JC virus and (b), TT 
virus (c). The query sequences (highlighted in yellow in phylogenetic view) were mapped to reference 
virus genome sequences to identify virus specific subtype. A blast alignment and phylogenetic view of the 






Supplementary Figure S5. Multiple sequence alignment using ClustalW for large VP1 protein. Overall 
protein similarity score was high (more than 93%), however, there were amino acid substitutions and are 










Supplementary Figure S6. Predicted residue binding sites for VP1 protein in reference Dunlop (1a) strain 
and B9/RU13 (IV) and B12/A-62H (1a) from two BKV+ patient’s described in this study. Predicted binding 
sites for ligand sialic acid (SIA) are highlighted with circle. The residue binding sites for Dunlop and other 











Supplementary Figure S7. Multiple sequence alignment using ClustalW for VP2 protein. Overall protein 















Supplementary Figure S8. Multiple sequence alignment using ClustalW for VP2 protein. Multiple 
sequence alignment revealed a nucleotide substitution at position 1257 in BKV genome B10/A-47H (1b2), 












Supplementary Figure S9. Analysis of VP2 protein of BK virus. (a) The Ramachandran plot for the phi-
psi torsion angles for residues in the VP2 protein of Dunlop (1a) (reference BKV subtype), B9/RU13 (IV) 
and B12/A-62H (1a) from BKV+ kidney transplant group. The coloring/shading on the plot represents the 
different regions described in Morris et al. (1992): the darkest areas (red) correspond to the "core" regions 
representing the most favorable combinations of phi-psi values. Over 90% of the residues in the "core" 
regions predicts a good quality structure model. The different regions on the Ramachandran plots are 
labelled as follows: A - Core alpha L - Core left-handed alpha a - Allowed alpha l - Allowed left-handed 
alpha ~a - Generous alpha ~l - Generous left-handed alpha B - Core beta p - Allowed epsilon b - Allowed 














Supplementary Figure S10. Predicted residue binding sites for VP2 protein in reference Dunlop (1a) strain 
and B9/RU13 (IV) and B12/A-62H (1a) from two BKV+ patient’s described in this study. The residue 
binding sites for Dunlop (1a) and other BKV sequences were predicted using the COFACTOR algorithm 
























































Supplementary Figure S11. Multiple sequence alignment using ClustalW for large T-antigen protein. 
Overall protein similarity score was high (more than 98%) however, there were amino acid substitutions 









Supplementary Figure S12.  Predicted residue binding sites for Large T antigen protein in reference 
Dunlop (1a) strain B9/RU13 (IV) and B12/A-62H (1a) from two BKV+ patient’s described in this study. 
Predicted binding sites for ligand ATP are highlighted with circle. The residue binding sites for Dunlop 






















Supplementary Table S1. Number of virus reads in percent counts. 
 The relative abundance values are calculated form the total read counts for each virus.  
 
 






B3 100.00 0.00 0.00 0.00 0.00 0.00 0.00 
B4 99.84 0.13 0.00 0.02 0.00 0.00 0.00 
B5 99.93 0.00 0.00 0.00 0.06 0.00 0.00 
B6 100.00 0.00 0.00 0.00 0.00 0.00 0.00 
B7 99.58 0.42 0.00 0.00 0.00 0.00 0.00 
B8 99.99 0.01 0.00 0.00 0.00 0.00 0.00 
B9 100.00 0.00 0.00 0.00 0.00 0.00 0.00 
B10 99.99 0.01 0.00 0.00 0.00 0.00 0.00 
B11 99.89 0.10 0.00 0.01 0.00 0.00 0.00 
B12 100.00 0.00 0.00 0.00 0.00 0.00 0.00 
B13 100.00 0.00 0.00 0.00 0.00 0.00 0.00 
B15 99.97 0.02 0.01 0.00 0.00 0.00 0.00 
BKV- 
B16 8.44 91.34 0.00 0.00 0.00 0.00 0.21 
B17 61.07 38.86 0.01 0.00 0.00 0.00 0.06 
B18 0.78 99.18 0.03 0.00 0.00 0.01 0.00 
B19 13.70 80.00 0.12 0.00 6.11 0.05 0.01 
B20 1.69 1.69 0.00 11.86 0.00 3.39 81.36 
B21 0.00 0.00 0.00 25.00 25.00 25.00 25.00 
B22 66.67 0.00 0.00 0.00 0.00 33.33 0.00 
B23 18.18 0.00 0.00 36.36 18.18 18.18 9.09 
B24 11.11 0.00 0.00 33.33 33.33 11.11 11.11 
B25 0.00 37.50 0.00 0.00 0.00 37.50 25.00 
B26 0.00 91.78 0.00 5.48 1.37 1.37 0.00 
B27 6.67 13.33 0.00 26.67 20.00 0.00 33.33 
B28 0.00 0.00 0.00 0.00 50.00 0.00 50.00 
B29 0.00 0.00 0.00 3.85 80.77 11.54 3.85 
B30 0.00 0.00 0.00 64.29 21.43 7.14 7.14 
Supplementary Table S2a. BKV virus count and subtype distribution in BKV+ kidney transplant group. 
Sample  Reference Subtype Genome Size (bp) Virus count# 
B3 (BKV+) BKV J2B-2 Ib1 5,141 192,450 
 
B4 (BKV+) BKV A-47H Ib2 5,141 193,513 
 
B5 (BKV+) 
BKV SJH-LG-309 Ib1 5,134 28,544 
BKV J2B-2 Ib1 5,141 27,932 
BKV SJH-LG-304 Ib1 5,141 14,011 
BKV VP1M26 I 5,141* 12,628 
BKV WT Ia 5,216 12,424 
BKV SJH-LG-306 Ib1 5,141 11,973 
BKV VP1M27 I 5,141* 10,583 
Human Papovavirus BK - 5,153 3,836 
BKV ANY-63 Ic 5,142 2,612 
BKV SUSH/SGPGI - 5,141* 2,064 
BKV HI-u8 Ib1 5,132 874 
 
B6 (BKV+) 
BKV SJH-LG-309 Ib1 5,134 79,134 
BKV SJH-LG-306 Ib1 5,141 46,619 
BKV J2B-2 Ib1 5,141 39,167 
BKV WT Ia 5,216 15,444 
BKV Tun-36 - 5,141* 7,980 
BKV_ISR_E_V7.1 - 5,141* 815 
BKV VP1M26 I 5,141* 71 
 
B7 (BKV+) BKV LAB27 Ib1 5,141 190,748 
 
B8 (BKV+) BKV  LAB27 Ib1 5,141 192,440 
 
B9 (BKV+) 
BKV RU13 IV 5,146 204,955 
BKV SJH-LG-309 Ib1 5,134 725 
 
B10 (BKV+) BKV A-47H Ib2 5,141 112,576 
     
B11 (BKV+) 
BKV RU13 IV 5,146 1 
BKV A-47H Ib2 5,141 494 
     
B12 (BKV+) BKV A-62H Ia 5,141 51,398 
 
B13 (BKV+) 
BKV A-62H Ia 5,141 100,447 
BKV WT Ia 5,216 20,110 
BKV for LT - 4,963 14,247 
BKV-D Ia 5,172 8,229 
BKV VP1M23 I 5,141* 3,923 
BKV  CAF-2 - 5,141* 3,130 
BKV VP1M27 I 5,141* 98 
BKV isolate patient 107 - 5,141* 17 
BKV SJH-LG-308 Ib2 5,141 4 
 
B15 (BKV+) 
BKV A-62H Ia 5,141 4,232 
BKV  WT Ia 5,216 2,233 
 
#Virus count: Reads per kb per million reads (RPKM) = (10^9 * C)/(N * L), where C = Number of reads mapped to BK 
virus, N = Total reads in the sample used for analysis, L = Genome length in base-pairs for BK virus (from NCBI Genome). 





Supplementary Table S2b. BKV virus count and subtype distribution in BKV- kidney transplant group. 
 
Sample  Reference Subtype Genome Size (bp) Virus count# 
B16 (BKV-)  
BKV A-62H  Ia 5141 31 
BKV ANY-63  Ic 5142 11 
BKV BKV-D Ia 5172 26 
BKV SJH-LG-168 Ib1 5141 27 
BKV SJH-LG-306 Ib1 5141 3 
BKV SJH-LG-309 Ib1 5134 15 
 
B17 (BKV-)  
BKV  A-62H Ia 5141 1453 
BKV SJH-LG-168  Ib1 5141 11 
BKV SJH-LG-309  Ib1 5134 176 
BKV J2B-9 Ib2 5141 50 
 
B18 (BKV-)  
BKV A-62H  Ia 5141 41 
BKV J2B-2  Ib1  5141 2 
BKV VNM-9  Ib1  5141 16 
 
B19 (BKV-)  
BKV A-62H   Ia 5141 3 
BKV J2B-2   Ib1  5141 110 
 
#Virus count: Reads per kb per million reads (RPKM) = (10^9 * C)/(N * L), where C = Number of reads mapped to BK virus, 








































#Virus count: Reads per kb per million reads (RPKM) = (10^9 * C)/(N * L), where C = Number of reads mapped to JC virus, 
N = Total reads in the sample used for analysis, L = Genome length in base-pairs for JC virus (from NCBI Genome). 










Sample Reference Subtype Genome Size (bp) Virus count# 
B5 (BKV+) 
JCV BJ-1 7B-1 5121* 0.5 
JCV ZJ-1 7B-1 5120 3.4 
 
B6 (BKV+) JCV BJ-1 7B-1 5121* 0.3 
     
B13 (BKV+) 
JCV OH-1 - 5147 1074 
JCV ML-2 - 5116 3.8 
JCV ZJ-1 7B-1 5120 1.2 
JCV BJ-1 7B-1 5121* 0.3 
JCV JAL 7A; SC-f 5121* 0.2 
 
B15 (BKV+) 
JCV ML-2 - 5116 2588 
JCV ZJ-1 7B-1 5120 4576 
JCV/5386/KW - 5121* 2.8 
JCV SL-15 - 5119 1.6 
 
B16 (BKV-) JCV SP-1 1B 5122 8251 
 
B17 (BKV-) 
JCV SP-1 1B 5122 8246 
JCV CPN1 - 5121* 790 
JCV 173FLC-05 - 5121* 312 
JCV VSO-2 - 5121 304 
JCV 603 - 5121* 59 
 
B18 (BKV-) 
JCV OH-1 - 5147 0.3 
JCV 9 - 5121* 0.3 
JCV ZJ-1 7B-1 5120 0.3 
JCV176FLC-10 - 5121* 0.2 
JCV 406 - 5121* 0.2 
 
B19 (BKV-) 
JCV ZJ-1 7B-1 5120 2.2 
JCV RJ/2005-07 - 5121* 1.5 
JCV UK-1 1B 5122 1.4 
JCV 183FLC-01 - 5121* 1.0 
JCV MC-8 - 5121 0.9 
JCV 149URNFL-13 - 5121* 0.8 
JCV FL-8 1 5121 0.5 
 Supplementary Table S4a. TT virus count and subtype distribution in BKV+ kidney transplant group. 
Sample Reference Genome Size (bp) Virus count# 
B4 (BKV+) 
TTV HD14h 3,725 275.1 
TTV sle2552 1,509 179.5 
TTVyon-LC011 3,675 15.6 
TTV genotype 23 3,792 13.5 
TTV 3CR11 3,725* 10.5 
TTV SIA109 3,260 5.3 
B5 (BKV+) 
TTV Polish isolate P/1C1 3,756 11.3 
TTV isolate L02 3,206 0.4 
B6 (BKV+) 
TTV ViPi04 3,774 1.9 
TTV HD22 (rheu112) 3,816 0.9 
TTV HD11 sle2037 3,814 0.6 
TTV CT25F 3,726 0.3 
 B7 (BKV+) 
TTV 21 TCHN-B 3,153 1464.4 
TTV 5 TCHN-C1 3,229 416.0 
TTV CT25F 3,726 340.3 
TTV L018 3,725* 210.8 
TTV genotype 23 3,792 94.9 
TTV 20 SAa-10 3,234 87.8 
TTV 29  TTVyon-KC009 3,676 46.4 
TTV JA10 3,539 41.3 
TTV TYM9-cDNA d-1 2,297 40.6 
TTV JT19F 3,676 25.2 
TTV 3 HEL32 3,748 20.7 
TTV 19 SANBAN 3,808 11.0 
TTV 3CR11 3,725* 7.6 
TTV mini  LIL-y1 2,887 3.4 
TTV mini 1 TLMV-CBD279 2,856 2.8 
TTV mini TLMV-CLC205 2,841 2.8 
B8 (BKV+) 
TTV SAf-09 3,155 16.0 
TTV L018 3,725* 12.6 
TTV 5 TCHN-C1 3,229 6.2 
TTV 3 HEL32 3,748 5.6 
TTV mini LIL-y1 2,887 1.1 
B10 (BKV+) 
TTV midi Pt-TTMDV225-2 3,269 581.2 
TTV midi  MDJN91 3,183 19.6 
B13 (BKV+) 
TTV midi Pt-TTMDV225-2 3,269 62.5 
TTV TUPB 3,817 12.3 
TTV midi MDJN91 3,183 2.0 
TTV ViPi04 3,774 1.8 
TTV CT25F 3,726 1.2 
B15 (BKV+) 
TTV TUPB 3,817 32.4 
TTV KC005/2-21E 3,725* 0.4 
 
#Virus count: Reads per kb per million reads (RPKM) = (10^9 * C)/(N * L), where C = Number of reads mapped to TT virus, 
N = Total reads in the sample used for analysis, L = Genome length in base-pairs for TTV (from NCBI Genome). *Predicted 
average genome size. 
 Supplementary Table S4b. TT virus count and subtype distribution in BKV- kidney transplant group. 
Sample Reference Genome Size (bp) Virus count# 
B16 (BKV-) 
TTV HD14h 3727 6795.2 
TTV tth4 3772 6476.5 
TTV tth26 3756 2628.5 
TTV tth21 3741 2516.0 
TTV-HD20b 3834 2496.4 
TTV-HD17 3756 2436.0 
TTV ZC-1998-2 3725 796.7 
TTV midi  MDJHem3-2 3197 705.3 
TTV midi MDJN1 3223 298.3 
TTV midi  1 MD1-073 3242 284.8 
TTV-HD20d 3880 254.9 
TTV midi  Pt-TTMDV210 3257 254.3 
TTV midi L67NA1 3725 250.0 
TTV 27  CT23F 3729 123.6 
TTV midi MDJN97 3223 121.9 
TTV-HD20f 3881 109.7 
TTV midi  L83NA1 3725 84.6 
TTV JT19F 3676 45.2 
TTV midi MDJN51 3187 20.8 
TTV ViPi08 3479 7.5 
TTV CT30F 3570 3.9 
TTV CT25F 3726 3.2 
TTV mini 5 TGP96 2908 3.2 
TTV CT43-14 3725 1.8 
TTV JT41F 3727 1.6 
TTV midi  L92NA1 3725 0.6 
 
B17 (BKV-) 
TTV CT25F 3726 4167.6 
TTV 3 HEL32 3748 1343.0 
TTV midi MDJHem5 3205 1436.9 
TTV tth29 3700 1101.0 
TTV mini 5 TGP96 2908 867.6 
TTV 16 TUS01 3818 493.7 
TTV midi MDJN69 3230 110.0 
TTV tth21 3741 8.8 
TTV HD20a 3878 5.5 
TTV HD20f 3881 1.2 
TTV HD14i 3726 1.1 
TTV CT25-05 3725 1.0 
TTV HD14d 3728 0.8 
TTV-HD14h 3727 0.8 
 B18 (BKV-) 
TTV HD22 3816 402.6 
TTV ViPi08 3479 343.0 
TTV JT41F 3727 69.2 
TTV sle2550 3725 21.9 
TTV KC009/2-3G 3725 13.0 
TTV ViPi04 3774 6.6 
TTV sle2552 1509 1.7 
TTV SIA109 3260 0.3 
TTV HD24f 3758 0.3 
TTV HD13c gsB21.51 3749 0.1 
    
B19 (BKV-) 
TTV SIA109 3260 582.2 
TTV 24  SAa-01 3246 226.0 
TTV  CT25F 3726 157.3 
TTV HD15d 3700 145.2 
TTV Polish isolate P/1C1 3756 21.6 
TTV KC009/2-3G 3725 8.3 
TTV  HD13c gsB21.51 3749 2.8 
TTV L02 3206 1.5 
TTV 3CR08 3725 1.5 
TTV HD13a gsB20.33 3749 1.2 
TTV T3PB 3838 0.9 
TTV HD20f 3881 0.2 
 
 
#Virus count: Reads per kb per million reads (RPKM) = (10^9 * C)/(N * L), where C = Number of reads mapped to TT virus, 





























































BKV JCV TTV  
Sample 
average 
B3 1.0 0.0 0.0 0.3 
B4 1.0 0.0 6.0 2.3 
B5 11.0 2.0 2.0 5.0 
B6 7.0 1.0 4.0 4.0 
B7 1.0 0.0 17.0 6.0 
B8 1.0 0.0 5.0 2.0 
B9 2.0 0.0 0.0 0.7 
B10 1.0 0.0 2.0 1.0 
B11 2.0 0.0 0.0 0.7 
B12 1.0 0.0 0.0 0.3 
B13 9.0 5.0 5.0 6.3 
B15 2.0 4.0 2.0 2.7 
Group 
Average 
3.3 1.0 3.6 2.6 
          
B16 6.0 1.0 26.0 11.0 
B17 4.0 5.0 14.0 7.7 
B18 3.0 5.0 10.0 6.0 
B19 2.0 7.0 11.0 6.7 
B20 1.0 0.0 1.0 0.7 
B21 0.0 0.0 0.0 0.0 
B22 0.0 1.0 0.0 0.3 
B23 1.0 0.0 0.0 0.3 
B24 1.0 0.0 0.0 0.3 
B25 0.0 0.0 1.0 0.3 
B26 0.0 0.0 1.0 0.3 
B27 1.0 0.0 1.0 0.7 
B28 0.0 0.0 0.0 0.0 
B29 0.0 0.0 0.0 0.0 
B30 0.0 0.0 0.0 0.0 
Group 
Average 
1.3 1.3 4.3 2.3 
  
Supplementary Table S6. RM plot statistics of VP1 protein for reference DUNLOP and two BKV+ samples 

























RM Plot Statistics DUNLOP B9 B12 
 Residues 
Residues in most favored regions [A,B,L] 211 (70.3%) 204 (68.0%) 211 (70.3%) 
Residues in additional allowed regions [a,b,l,p] 80 (26.7%) 82 (27.3%) 76 (25.3%) 
Residues in generously allowed regions [~a,~b,~l,~p] 8 (2.7%) 11 (3.7%) 9 (3.0%) 
Residues in disallowed regions 1 (0.3%) 3 (1.0%) 4 (1.3%) 
Number of non-glycine and non-proline residues 300 (100%) 300 (100%) 300 (100%) 
 
Number of end-residues (excl. Gly and Pro) 2 2 2 
Number of glycine residues (shown as triangles) 31 31 31 
Number of proline residues 28 29 28 
Total number of residues 361 362 361 
  
 
Supplementary Table S7. Nucleotide substitution observed in VP2 protein in sample B10 (BKV+ sample) 















TAT Y (Tyr) 
A-47H Ib2 TAT Y (Tyr) 




ACA T (Thr) 
A-47H Ib2 TGA * 
B10 Ib2 TAA * 
 































 Supplementary Table S8. RM plot statistics of VP2 protein for reference DUNLOP and two BKV+ samples 





















RM Plot Statistics DUNLOP B9 B12 
 Residues  
Residues in most favored regions [A,B,L] 206 (66.7%) 207 (67.0%) 221 (71.5%) 
Residues in additional allowed regions [a,b,l,p] 77 (24.9%) 77 (24.9%) 74 (23.9%) 
Residues in generously allowed regions [~a,~b,~l,~p] 16 (5.2%) 16 (5.2%) 8 (2.6%) 
Residues in disallowed regions 10 (3.2%) 9 (2.9%) 6 (1.9%) 
Number of non-glycine and non-proline residues 309 (100%) 309 (100%) 309 (100%) 
 
Number of end-residues (excl. Gly and Pro) 2 2 2 
Number of glycine residues (shown as triangles) 25 25 25 
Number of proline residues 15 15 15 
Total number of residues 351 585 585 
Supplementary Table S9. RM plot statistics of Large T antigen protein for reference DUNLOP and two 
BKV+ samples from BKV+ kidney transplant group. 
 
RM Plot Statistics DUNLOP B9 B12 
 Residues  
Residues in most favored regions [A,B,L] 393 (73.9%) 381 (71.6%) 397 (74.6%) 
Residues in additional allowed regions [a,b,l,p] 104 (19.5%) 105 (19.7%) 102 (19.2%) 
Residues in generously allowed regions [~a,~b,~l,~p] 20 (3.8%) 28 (5.3%) 21 (3.9%) 
Residues in disallowed regions 15 (2.8%) 18 (3.4%) 12 (2.3%) 
Number of non-glycine and non-proline residues 532 (100%) 532 (100%) 532 (100%) 
 
Number of end-residues (excl. Gly and Pro) 2 2 2 
Number of glycine residues (shown as triangles) 25 25 25 
Number of proline residues 26 26 26 











Supplementary Table S10. Virus identified in BKV+ and BKV- group. 
 
Virus 
BKV+ BKV - 
B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 B13 B15 B16 B17 B18 B19 B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 B30 
Mardivirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Cytomegalovirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Alpha- 
Papillomavirus n 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 
Beta- 
Papillomavirus n 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.3 28.6 0.0 2.6 16.7 0.0 0.0 26.7 
Gamma- 
Papillomavirus n 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 
Chlorovirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Polyomavirus 
BK 
100.0 99.8 99.9 100.0 99.6 100.0 100.0 100.0 99.9 100.0 99.9 99.9 0.0 14.7 67.1 11.2 96.7 20.0 0.0 26.7 28.6 8.3 0.0 0.0 4.3 0.0 0.0 
Polyomavirus 
JC 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.2 51.6 0.0 1.1 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Totivirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 
Lentivirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 
Alpha- 
torquevirus 
0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.7 1.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 
Beta- 
torquevirus 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Gamma- 
torquevirus 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Begomovirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Ilarvirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Sapovirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 6.7 0.0 0.0 1.3 0.0 0.0 10.0 0.0 
Enterovirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Mastadenovirus 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 20.0 20.0 0.0 8.3 3.9 8.3 91.3 30.0 20.0 
Other viruses 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 20.0 20.0 13.3 14.3 25.0 1.3 0.0 0.0 30.0 6.7 
Unclassified 
Papillomaviridae 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.0 0.0 13.3 14.3 0.0 1.3 16.7 0.0 10.0 26.7 
Unclassified 
Anelloviridae 
0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 87.9 30.8 31.1 83.8 0.1 0.0 0.0 0.0 0.0 25.0 81.6 16.7 0.0 0.0 0.0 
Unclassified 
viruses 
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.6 20.0 0.0 6.7 14.3 16.7 0.0 41.7 4.3 10.0 6.7 
The relative abundance values are calculated form the total read counts for each virus.  
